The detection of the benefit of simvastatin predominantly amongst those homozygous for the at-risk CC genotype of Y402H of the CFH gene suggests that in future studies, genotype should be taken into consideration when assessing the potential effect of statins in AMD. The gene discussed is CFH; the disease is age-related macular degeneration.